It is a great pleasure to inform you about the collaboration between Swiss HLG and our international network IPLS (www.ipls.online) for the next spring conference “Rebound & Recover” planned for 21st-22nd April.
At this occasion, you’ll have the opportunity to set up virtual one-to-one business meetings with your peers, without traveling, over 2 days and participate to several conferences to keep you up-to-date about the trends in our industry. This will help you and your business during this pandemic to substitute your business travels.
Take advantage of the early bird rate and register asap at: www.ipls.online. If you need any help please contact Adam Collins at acollins@ngaevents.co.uk or Andrew Dean at andrew.dean@presentvalueltd.com
Several sponsoring opportunities are also offered, to give more visibility to your company and business inside this network of over 1’700 BD&L professionals. Join current sponsors:
Financing and Deal-making in turbulent times, 2nd March 2021, 3.00pm – 6.00pm CET
IPLS Online Event: 16th – 17th September 2020
IPLS Bright Online Conference is now open for registration.
Full access to the event website where the presentations will be broadcast, video content, details of the programme and speakers & online partnering system. Full Access Pass – €100.00 (EUR).
Simply click here to register!
| 08.00 – 18.00 | Online Partnering – 25 minutes per meeting |
| MORNING SESSION | |
| 08.45 | Registration |
| 09.00 | Welcome & Introduction |
| 09.05 | Keynote Address SHAUN GRADY AstraZeneca |
| 09.25 | Covid-19: The First 6 Months ANDREW DEAN Present Value |
| 09.45 | Biopharmaceutical Sector: Financing and Deal Making Outlook STEPHANIE LEOUZON Torreya |
| 10.05 | Global Pipeline Overview |
| 10.25 | Closing Remarks |
| 10.30 | Close of Morning Session |
| AFTERNOON SESSION | |
| 15.15 – 15.30 | Registration |
| 15.30 | Innovation from The Crick BARBARA DOMAIN HAYMAN The Francis Crick Institute |
| 15.50 | What’s Hot in Oncology Deal Making- Where is the Low Hanging Fruit? CHRIS SHELDON AstraZeneca |
| 16.10 | Gene Therapy Comes of Age |
| 16.30 | BREAK |
| 16.40 | The Application of AI in Rare Diseases BRUCE E. BLOOM & CLARA TANG Healx |
| 17.00 | Pricing and Market Access in Rare Diseases RAVI SODHA Sodha Pharma Consulting |
| 17.20 | Closing Remarks |
| 17.25 | Close of Day 1 |
| 08.00 – 18.00 | Online Partnering – 25 minutes per meeting |
| 08.45 | Registration |
| 09.00 | Panel Discussion: Building Business Development Relationships in Covid-19 times GEORG BUCHNER Helsinn Healthcare CHRIS VAES J&J JEAN-MARC SEQUIER Novartis TORU J. SEO Pfizer MICHAEL CROWLEY F. Hoffann-La Roche |
| 09.45 | Panel Discussion: Impact of Covid-19 on Promotional Activities, Could Covid-19 Boost a Change of the Current Paradigm? LARS BOERGER Alliance Pharma BENOIT SLAVICEK Mundipharma |
| 10.30 | Closing Remarks |
| 10.35 | Close of IPLS Bright Online |
The Swiss HLG, a non-profit association of Business Development and Licensing professionals, held its 31st Conference titled “DEAL-MAKING IN THE ROUGH”, in a beautiful setting in the Swiss Alps. The topic of discussion focused on the fact we are living in provoking times: The pharmaceutical and biotech industry as a whole and the professional business developers, alliance managers and dealmakers have to cope with a disruptive and changing environment in which deal making will become more and more complex and ambitious.
Over two and a half days, more than 85 delegates from Switzerland, Europe, the US and Asia gathered in the Swiss Alps to explore and discuss new trends in partnering and deal-making in the current tumult of our industry with the overall objective to capture the maximum value with professional capabilities and high-calibre talents.
